Form 4: UNH Director Charles Baker Acquires 279 Deferred Stock Units

UnitedHealth Group director Charles D. Baker acquired 279 deferred stock units as part of his regular quarterly compensation.

Summary

• Charles D. Baker, a director of UnitedHealth Group Inc. (UNH), acquired 279 shares of common stock on January 2, 2026.
• The acquisition was made at a price of $0 per share, indicating a grant rather than a purchase.
• These shares represent deferred stock units (DSUs) granted as regular quarterly compensation for his service as a director.
• The deferred stock units are immediately vested but must be retained by Mr. Baker until his completion of service on the Board.
• Following this transaction, Mr. Baker directly beneficially owns 1,806 shares of UnitedHealth Group common stock.

Sentiment

Score: 7

Explanation: The filing reports a routine compensation grant to a director, which is a positive for aligning interests but not a significant market-moving event on its own. It reflects stable corporate governance practices.

Positives

• Director Charles D. Baker received 279 deferred stock units as part of his regular quarterly compensation, indicating ongoing director service and alignment with shareholder interests.
• The deferred stock units are immediately vested, providing certainty of ownership for the director.

Future Outlook

The filing does not contain specific forward-looking statements or guidance beyond the nature of the deferred stock units requiring retention until the director's completion of service.

Industry Context

This Form 4 filing reports a routine compensation-related equity grant to a director, which is a common practice across publicly traded companies in the healthcare industry and beyond to align management and director interests with shareholders.

Comparison to Industry Standards

• The grant of deferred stock units as compensation for director service is a standard practice in corporate governance across various industries, including healthcare, aligning director incentives with long-term company performance.
• The immediate vesting of these units, coupled with a retention requirement until service completion, is a common structure designed to ensure continued commitment and long-term perspective from board members.

Corporate Governance

Stakeholder Impact

• Shareholders: The grant of deferred stock units to a director aligns the director's financial interests with long-term shareholder value, as the units must be retained until service completion.
• Employees: No direct impact on general employees is indicated by this director compensation filing.

Next Steps

• No specific future actions or milestones are mentioned in this transactional filing, other than the director's continued service on the Board.

Key Dates

Recommendation

This Form 4 filing reports a routine grant of deferred stock units to a director as part of their regular compensation. Such a transaction is standard practice for publicly traded companies and does not provide new information that would alter the fundamental investment outlook for UnitedHealth Group. It primarily serves to align director interests with long-term shareholder value. Therefore, a 'hold' recommendation is appropriate as this event does not warrant a change in investment strategy.

Keywords

UnitedHealth Group, UNH, Form 4, Director Compensation, Deferred Stock Units, Equity Grant, Beneficial Ownership